The use of FAPI-PET/CT scan and FDG-PET-CT scan in acute phase Peyronie's disease for detection of active fibroblasts and inflammation in the penis - a pilot study

The use of FAPI-PET/CT scan and FDG-PET-CT scan in acute phase Peyronie's disease for detection of active fibroblasts and inflammation in the penis - a pilot study - Hippocrates

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON56999

Enrollment

Registered

2023-12-12

Start date

2024-12-13

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benigne fibroblast vorming in de Tunica Albuginea van de penis bij mannen curvature penis Peyronie's disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: painful erections onset for 18 years of age Mentally competent and understanding of benefits and potential burden of the study Be able to sign written infromed consent read and understand Dutch

Exclusion criteria

Exclusion criteria: Known other malignant disease previous treatment for Peyronie's disease

Design outcomes

Primary

Measure	Time frame
Detection of active fibroblasts (uptake of FAPI) and/or inflammation (uptake of FDG) in the penis of PD patients with FAPI-PET/CT scan and FDG-PET/CT scan.	—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results